Pharma Co. Snags $100M To Advance Psychedelic Treatment
The pharmaceutical arm of the nonprofit Multidisciplinary Association for Psychedelic Studies said on Friday it raised $100 million in an initial round of financing as it transitions to new leadership....To view the full article, register now.
Already a subscriber? Click here to view full article